Advocacy intelligence hub — real-time data for patient organizations
National Institute of Allergy and Infectious Diseases (NIAID)
Merck Sharp & Dohme LLC — PHASE2
Erasca, Inc. — PHASE1
Celgene — PHASE3
National Institute of Allergy and Infectious Diseases (NIAID)
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Hanny Al-Samkari, MD
Massachusetts General Hospital
📍 Miami, Florida
Ann (Annie) W Silk
Dana-Farber - Harvard Cancer Center LAO
📍 Los Angeles, California
Michael Ortiz, MD
Memorial Sloan Kettering Cancer Center
Cheryl L. Willman, MD, MD
University of New Mexico Cancer Center
📍 ALBUQUERQUE, TX
Yuankai Shi, MD
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
John Matthews, MBBS, MCRP, PhD
The University of Alabama at Birmingham
📍 Birmingham, Alabama
View all Other Congenital Malformation Syndromes specialists →